SCHEMBL13439305

SCHEMBL13439305

CC(C)(C)c1cccc(OCC(=O)NCCc2ccc[nH]2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ TRPV1 Q8NER1 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ SOD1 P00441 1/20 0.43
▸ PTPN1 P18031 1/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ PPARG P37231 1/20 0.41
▸ NCOA2 Q15596 1/20 0.41
▸ NCOA1 Q15788 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ NR2E3 Q9Y5X4 1/20 0.41
▸ NCOR2 Q9Y618 1/20 0.41
▸ NCOA3 Q9Y6Q9 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13439415 0.82 RAB9A (0.47) FFAR1KDM4EPTPN1MEN1HTT
SCHEMBL13439306 0.78 LGALS1 (0.55) FFAR1KDM4ETRPV1HPGDMEN1
SCHEMBL12082548 0.75 SYK (0.58) FFAR1KDM4ETRPV1SOD1HTT
SCHEMBL27090181 0.72 KMT2A (0.53) FFAR1KDM4ETRPV1HPGDMEN1
SCHEMBL29754911 0.72 KMT2A (0.53) FFAR1KDM4ETRPV1HPGDMEN1
SCHEMBL12993061 0.71 ALDH1A1 (0.51) FFAR1KDM4ETRPV1SOD1MEN1
SCHEMBL30831879 0.71 SMN1; SMN2 (0.65) FFAR1SOD1PPARGLMNA
SCHEMBL1986392 0.71 SMN1; SMN2 (0.65) FFAR1SOD1PPARGLMNA
SCHEMBL18120698 0.71 SOD1 (0.51) FFAR1KDM4ETRPV1SOD1HTT
SCHEMBL14065575 0.70 KDM4E (0.51) FFAR1KDM4ETRPV1SOD1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933077-B2 Glucokinase activators ARRAY BIOPHARMA INC. (US) 2015-01-13 — — US disclosed
US-20100056530-A1 GLUCOKINASE ACTIVATORS ARRAY BIOPHARMA INC. (US) 2010-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056530-A1 GLUCOKINASE ACTIVATORS GCKR, GCK, GALK1 FFAR1 1580/4885KDM4E 2723/4885TRPV1 4787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback